Tuberculosis
Diagnostics Market study is providing you with the up-to-date,
actionable market information and projections with the latest impact of the
Covid 19 outbreak. It offers all the requisite data to support tactical
business decisions and come up with strategic growth plans. This study also
proposes a comprehensive insight into the development policies and plans in
addition to manufacturing processes and cost structures.
Global
Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024
owing to the introduction of enhanced diagnostic techniques like serological
methods, IGRA (Interferon-gamma Release Assay), and nucleic acid testing.
Tuberculosis is an infectious disorder caused by mycobacterium tuberculosis
bacteria that attacks the lungs. The disorder can also spread to the other
parts of the body like spine and brain. Depending on the type of tuberculosis
suspected in the body, several tests are available for the diagnosis.
Download Free Sample Report Now @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market/request-sample
Tuberculosis
diagnostics industry is influenced by factors like quick results and improved
accuracy, increasing government initiatives, growing elderly population and
rising need for POC in healthcare sector. However, tuberculosis diagnostics
market is restrained by significant cost of tuberculosis diagnosis and lack of
awareness in patients. Additionally, the increasing burden of tuberculosis is
the major factor expected to bring greater opportunities in tuberculosis
diagnostics industry.
Tuberculosis
diagnostics market is categorized on the basis of test type, end user, and
geography. On the basis of test type, the market is divided into diagnostic
laboratory methods, detection of latent infection, nucleic acid testing,
cytokine detection assay, detection of drug resistance, radiographic method,
and others. Diagnostic laboratory segment is projected to hold larger market
share of tuberculosis diagnostics since it is easy to perform and cost
effective.
Based on end
user, tuberculosis diagnostics industry is divided into clinics, research
institutes & academics, reference laboratories, hospitals, and others.
Hospital segment is predicted to register significant growth in the coming
years owing to rising preference for well-organized healthcare services by
patients.
Geographically,
tuberculosis diagnostics market is segmented as North America, Latin America,
Europe, Asia Pacific and Middle East & Africa. North America is predicted
to lead the market of tuberculosis diagnostics owing to innovations in
technology, approval for novel medications and increasing incidences for TB in
young people.
The prominent
players in tuberculosis diagnostics industry include Abbott, BioMrieux SA, Hain
Lifescience GmbH, Siemens, Cepheid, Thermo Fisher Scientific Inc., Becton,
Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, and
Qiagen.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment